Emerging COVID-19 Variant 'Cicada' Raises Global Health Concerns
Introduction to the Cicada Variant
A new variant of COVID-19, referred to as 'Cicada', is gaining attention worldwide as cases begin to rise in various nations. Officially named BA.3.2, this variant belongs to the Omicron lineage and is concerning due to its significant number of mutations and rapid transmission potential. The Centers for Disease Control and Prevention (CDC) in the United States has reported a gradual increase in cases. Additionally, the World Health Organization has classified Cicada as a variant under monitoring as it appears in more countries. Currently, BA.3.2 has been identified in over 20 nations, with some regions reporting it accounts for up to 30% of cases. The CDC noted that tracking the spread of BA.3.2 is crucial for understanding its ability to evade immunity from previous infections or vaccinations.
Understanding the Cicada Variant
What is the Cicada Variant?
The Cicada variant was first identified in South Africa in late 2024 but remained relatively unnoticed until it resurfaced globally in 2025. Experts have noted that it possesses over 70 mutations in its spike protein, which is essential for the virus's entry into human cells. This raises concerns regarding two main factors:
- Increased transmissibility, indicating it spreads more easily.
- Potential immune escape, which may allow it to partially bypass immunity from vaccines or previous infections.
However, initial data suggests that while it may spread more rapidly, it does not appear to cause more severe illness compared to earlier variants. The name 'Cicada' was chosen because these insects typically remain hidden, similar to how this variant was initially undetected.
Geographical Spread of Cicada
Where is it Spreading?
The Cicada variant has been detected in more than 20 countries, including the United States, with certain areas in Europe reporting a significant number of cases. At least 25 states in the U.S. have found traces of Cicada in wastewater samples from 132 locations, indicating silent community transmission. Health experts caution that this variant could potentially lead to future waves of infection, although it has not yet become the dominant strain worldwide.
Symptoms to Monitor
Signs and Symptoms to Watch For
Experts indicate that the Cicada variant does not present significantly new symptoms but rather resembles those of previous Omicron variants. Common symptoms include:
- Fever or sudden chills
- Persistent cough
- Severe sore throat
- Fatigue and body aches
- Headache
- Runny or blocked nose
- Shortness of breath
- Nausea or digestive issues
- Skin rashes or eye irritation
As with earlier variants, asymptomatic cases are possible, allowing individuals to unknowingly transmit the virus.
Assessing the Risk
How Risky is It?
Currently, experts have not found clear evidence that the Cicada variant leads to more severe illness on a population level. This aligns with broader findings that newer variants often maintain similar severity, particularly among vaccinated individuals. The primary concern lies in its rapid spread, which could result in increased hospitalizations due to higher case numbers.
Recommendations from Experts
What Experts Recommend
Health authorities advise against panic but encourage caution. Existing vaccines are expected to continue providing protection against severe illness, hospitalization, and death. Experts recommend staying current with vaccinations and boosters, getting tested if symptoms arise, wearing masks in crowded or high-risk environments, and isolating if a positive test occurs. If symptoms worsen, particularly breathing difficulties or chest pain, seeking immediate medical attention is essential.